Cytotoxic potential of ribonuclease and ribonuclease hybrid proteins
- PMID: 1939162
Cytotoxic potential of ribonuclease and ribonuclease hybrid proteins
Abstract
Pancreatic RNase injected into Xenopus oocytes abolishes protein synthesis at concentrations comparable to the toxin ricin yet has no effect on oocyte protein synthesis when added to the extracellular medium. Therefore RNase behaves like a potent toxin when directed into a cell. To explore the cytotoxic potential of RNase toward mammalian cells, bovine pancreatic ribonuclease A was coupled via a disulfide bond to human transferrin or antibodies to the transferrin receptor. The RNase hybrid proteins were cytotoxic to K562 human erythroleukemia cells in vitro with an IC50 around 10(-7) M whereas greater than 10(-5) M native RNase was required to inhibit protein synthesis. Cytotoxicity requires both components of the conjugate since excess transferrin or ribonuclease inhibitors added to the medium protected the cells from the transferrin-RNase toxicity. Compounds that interfere with transferrin receptor cycling and compartmentalization such as ammonium chloride decreased the cytotoxicity of transferrin-RNase. After a dose-dependent lag period inactivation of protein synthesis by transferrin-RNase followed a first-order decay constant. In a clonogenic assay that measures the extent of cell death 1 x 10(-6) M transferrin-RNase killed at least 4 logs or 99.99% of the cells whereas 70 x 10(-6) M RNase was nontoxic. These results show that RNase coupled to a ligand can be cytotoxic. Human ribonucleases coupled to antibodies also may exhibit receptor-mediated toxicities providing a new approach to selective cell killing possibly with less systemic toxicity and importantly less immunogenicity than the currently employed ligand-toxin conjugates.
Similar articles
-
Rational immunotherapy with ribonuclease chimeras. An approach toward humanizing immunotoxins.Cell Biophys. 1992 Aug-Dec;21(1-3):121-38. doi: 10.1007/BF02789483. Cell Biophys. 1992. PMID: 1285324 Review.
-
Comparison of RNases and toxins upon injection into Xenopus oocytes.J Biol Chem. 1991 Nov 5;266(31):21208-14. J Biol Chem. 1991. PMID: 1939163
-
Cytotoxic ribonuclease chimeras. Targeted tumoricidal activity in vitro and in vivo.J Biol Chem. 1992 Sep 25;267(27):19572-8. J Biol Chem. 1992. PMID: 1527074
-
A cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity.J Biol Chem. 1993 May 15;268(14):10686-93. J Biol Chem. 1993. PMID: 8486718
-
Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.Curr Pharm Biotechnol. 2008 Jun;9(3):185-9. doi: 10.2174/138920108784567344. Curr Pharm Biotechnol. 2008. PMID: 18673284 Free PMC article. Review.
Cited by
-
Surveillance of Tumour Development: The Relationship Between Tumour-Associated RNAs and Ribonucleases.Front Pharmacol. 2019 Sep 13;10:1019. doi: 10.3389/fphar.2019.01019. eCollection 2019. Front Pharmacol. 2019. PMID: 31572192 Free PMC article. Review.
-
Barnase as a new therapeutic agent triggering apoptosis in human cancer cells.PLoS One. 2008 Jun 18;3(6):e2434. doi: 10.1371/journal.pone.0002434. PLoS One. 2008. PMID: 18560598 Free PMC article.
-
Polyarginine as a multifunctional fusion tag.Protein Sci. 2005 Jun;14(6):1538-44. doi: 10.1110/ps.051393805. Protein Sci. 2005. PMID: 15930002 Free PMC article.
-
Updates in the Development of ImmunoRNases for the Selective Killing of Tumor Cells.Biomedicines. 2018 Mar 5;6(1):28. doi: 10.3390/biomedicines6010028. Biomedicines. 2018. PMID: 29510557 Free PMC article. Review.
-
The transferrin receptor and the targeted delivery of therapeutic agents against cancer.Biochim Biophys Acta. 2012 Mar;1820(3):291-317. doi: 10.1016/j.bbagen.2011.07.016. Epub 2011 Aug 5. Biochim Biophys Acta. 2012. PMID: 21851850 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources